Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience
Articolo
Data di Pubblicazione:
2024
Citazione:
Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience / F. Migliore, M. Schiavone, R. Pittorru, G.B. Forleo, M. De Lazzari, G. Mitacchione, M. Biffi, S. Gulletta, J. Kuschyk, P.B. Dall'Aglio, G. Rovaris, R. Tilz, F.R. Mastro, S. Iliceto, C. Tondo, L. Di Biase, A. Gasperetti, V. Tarzia, G. Gerosa. - In: INTERNATIONAL JOURNAL OF CARDIOLOGY. - ISSN 0167-5273. - (2024 Jan), pp. 131807.1-131807.7. [10.1016/j.ijcard.2024.131807]
Abstract:
Background: Left ventricular assist devices (LVADs) are an increasingly used strategy for the management of patients with advanced heart failure (HF). Subcutaneous implantable cardioverter defibrillator (S-ICD) might be a viable alternative to conventional ICDs with a lower risk of short- and long-term of device-related complications and infections.The aim of this multicenter study was to evaluate the outcomes and management of S-ICD recipients who underwent LVAD implantation. Methods: The study population included patients with a preexisting S-ICD who underwent LVAD implantation for advanced HF despite optimal medical therapy. Results: The study population included 30 patients (25 male; median age 45 [38-52] years).The HeartMate III was the most common LVAD type. Median follow-up in the setting of concomitant use of S-ICDs and LVADs was 7 months (1-20).There were no reports of inability to interrogate S-ICD systems in this population. Electromagnetic interference (EMI) occurred in 21 (70%) patients. The primary sensing vector was the one most significantly involved in determining EMI. Twenty-seven patients (90%) remained eligible for S-ICD implantation with at least one optimal sensing vector. The remaining 3 patients (10%) were ineligible for S-ICD after attempts of reprogramming of sensing vectors. Six patients (20%) experienced inappropriate shocks (IS) due to EMI. Six patients (20%) experienced appropriate shocks. No S-ICD extraction because of need for antitachycardia pacing, ineffective therapy or infection was reported. Conclusions: Concomitant use of LVAD and S-ICD is feasible in most patients. However, the potential risk of EMI oversensing, IS and undersensing in the post-operative period following LVAD implantation should be considered. Careful screening for EMI should be performed in all sensing vectors after LVAD implantation.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Electromagnetic interference defibrillator; Heart failure; Inappropriate shocks; Left assist device; Subcutaneous implantable cardioverter
Elenco autori:
F. Migliore, M. Schiavone, R. Pittorru, G.B. Forleo, M. De Lazzari, G. Mitacchione, M. Biffi, S. Gulletta, J. Kuschyk, P.B. Dall'Aglio, G. Rovaris, R. Tilz, F.R. Mastro, S. Iliceto, C. Tondo, L. Di Biase, A. Gasperetti, V. Tarzia, G. Gerosa
Link alla scheda completa: